Contrast injection developer E-Z-EM this week is demonstrating its new EZ Chem blood analyzer as a work-in-progress at RSNA 2005 in Chicago.
EZ Chem is a point-of-care device for conducting blood assays in patients prior to certain imaging procedures, such as contrast CT exams, according to the Lake Success, NY, firm. E-Z-EM developed the product with Nova Biomedical of Waltham, MA, and has exclusive rights to market the product to radiologists and gastroenterologists in North America, with additional marketing rights worldwide.
E-Z-EM expects to submit its application to the FDA for clearance in the third quarter of 2006. Marketing could begin by late next year.
By AuntMinnie.com staff writers
November 29, 2005
Related Reading
Road to RSNA, E-Z-EM, November 4, 2005
E-Z-EM debuts IRiSCT, October 13, 2005
E-Z-EM notches record revenue in Q1, October 12, 2005
E-Z-EM joins new Nasdaq index, August 10, 2005
E-Z-EM turns in record fiscal 2005, August 2, 2005
Copyright © 2005 AuntMinnie.com
